CA2831054C — Formulations, and methods for their use in treatment of neuropathology and neurodegeneration as a result of traumatic injury
Assigned to SAPNA LIFE SCIENCES CORP · Expires 2016-08-30 · 10y expired
What this patent protects
The presently disclosed invention and particular invention embodiments relate to formulations, methods, procedures, and combinations thereof for treating numerous types of trauma-induced and other neurological disorders and injuries, such as but not exclusive to brain injury, cen…
USPTO Abstract
The presently disclosed invention and particular invention embodiments relate to formulations, methods, procedures, and combinations thereof for treating numerous types of trauma-induced and other neurological disorders and injuries, such as but not exclusive to brain injury, central nervous system ischemia, spinal cord injury, enteric nervous system injury and peripheral nerve injury. The formulations of the present invention comprising two, three or four biologically active compounds selected from: A. at least one biologically active compound selected from anticonvulsants and antiepileptics; B. at least one biologically active compound selected from neurosteroids and neuroactive steroids; C. at least one biologically active compound selected from NK-1 receptor antagonists; and D. at least one biologically active compound selected from lithium containing and lithium-related compounds.
Drugs covered by this patent
- Zurzuvae (ZURANOLONE) · Biogen
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.